1. Home
  2. NHC vs DNLI Comparison

NHC vs DNLI Comparison

Compare NHC & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National HealthCare Corporation

NHC

National HealthCare Corporation

N/A

Current Price

$189.06

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

N/A

Current Price

$18.47

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NHC
DNLI
Founded
1971
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.4B
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
NHC
DNLI
Price
$189.06
$18.47
Analyst Decision
Strong Buy
Analyst Count
0
21
Target Price
N/A
★ $35.82
AVG Volume (30 Days)
127.6K
★ 1.3M
Earning Date
11-06-2026
11-03-2026
Dividend Yield
★ 1.42%
N/A
EPS Growth
★ 17.46
N/A
EPS
★ 5.66
N/A
Revenue
★ $1,517,781,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$204.90
P/E Ratio
$33.38
★ N/A
Revenue Growth
★ 16.09
N/A
52 Week Low
$128.00
$15.34
52 Week High
$248.20
$27.30

Technical Indicators

Market Signals
Indicator
NHC
DNLI
Relative Strength Index (RSI) 28.43 43.32
Support Level $186.65 $18.24
Resistance Level $231.79 $21.45
Average True Range (ATR) 6.70 0.94
MACD -1.64 -0.10
Stochastic Oscillator 12.74 24.50

Price Performance

Historical Comparison
NHC
DNLI

About NHC National HealthCare Corporation

National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: